By Lily Kelly Contributing Writer Hope is on the horizon for needle phobics as researchers from Griffith University have ...

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production ...

Alternative dosing routes, such as rectal and intranasal (IN) routes, have been suggested as options for oral or intravenous administration. Rhinitis and pharmacological agents used for treatment ...

The following is a summary of “Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies,” published in the ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

Silo Pharma (NASDAQ: SILO) has entered into a collaboration with Kymanox to develop a subcutaneous insertion device for SP-26, its ketamine-loaded ...

Objective: To characterize the pharmacokinetic-pharmacodynamic correlation of intranasal and intravenous fentanyl in opioid-naïve patients undergoing third molar extraction. Methods: A double ...

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production ...

Oragenics, Inc. (NYSE: OGEN) announced in a recent Form 8-K filing to the Securities and Exchange Commission that it has decided not to renew the Employment Agreement of its President, J. Michael ...

Undocumented or subclinical influenza cases may explain why those who receive repeat influenza vaccines over multiple seasons ...

In case of a medical emergency such as a heart attack or overdose, here’s what you should — and shouldn’t — do until the ...

Prototype development and feasibility testing underway for optimized subcutaneous deliverySARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo ...